Wide and Narrow Complex Tachyarrhythmias



Wide and Narrow Complex Tachyarrhythmias


David V. Daniels

Amin Al-Ahmad



BACKGROUND AND APPROACH

The tachyarrhythmias presented in this chapter and the approach to their differential diagnosis, workup, and treatment are among the most common problems encountered in inpatient cardiology. These entities range in gravity from arrhythmias that are a nuisance, allowing for careful consideration as to the best approach, to life-threatening emergencies demanding decisive action.


DEFINITIONS



  • Narrow complex tachycardia: QRS duration <120 milliseconds


  • Wide complex tachycardia: QRS duration >120 milliseconds with or without pre-excitation


  • Pre-excitation: Initial “slurring” of the QRS complex implying manifest antegrade conduction down an accessory bypass tract (e.g., WPW pattern); may see in sinus rhythm atrial fibrillation (AF), or antidromic reciprocating tachycardia (ART)


  • Supraventricular tachycardia (SVT): A tachycardia arising from or involving the atria, specialized atrial conduction tissue, or compact A-V node


  • Though technically SVT includes AF, some exclude AF as a separate entity for the purposes of nomenclature for multiple reasons



  • Ventricular tachycardia (VT): A tachycardia arising from and exclusively involving the tissue beneath the compact portion of the AV node, including the His bundle, bundle branches, and ventricular myocardium


  • VT most commonly associated with CAD and/or structural heart disease


  • 10% of VT occurs in structurally normal hearts arising both from the endocardium1,2 and epicardium3


HISTORY



  • Symptoms include palpitations, dyspnea, chest pain, presyncope, syncope


  • History of myocardial infraction (MI), congestive heart failure (CHF) increase the risk of malignant arrhythmias such as VT


  • Implantable cardioverter-defibrillator (ICD) → consider VT


  • Drop attack (sudden syncope without prodrome) is suggestive of cardiac mediated syncope but its absence should not dissuade you from considering the diagnosis4


  • Palpitations are also commonly felt in the recovery phase of neurocardiogenic syncope


  • Consider the patient’s medications as an etiology of arrhythmias:



    • A-V nodal agents—see bradyarrhythmias


    • Antiarrhythmics—particularly those that prolong the QTc, IC agents (Flecainide, encainide (not available in the United States), propafenone), dofetilide, sotalol, amiodarone


    • QTc-prolonging nonantiarrhythmics—macrolides, fluoroquinolones, antipsychotics, etc.


    • Digoxin toxicity


PHYSICAL EXAM



  • Hypotension or clinical instability does not distinguish between SVT and VT!


  • Cannon A waves may be observed in the jugular venous pulse and in the setting of a wide complex tachycardia are indicative of A-V dissociation and highly suggestive of ventricular tachycardia


  • Crackles or wheezes may suggest heart failure but also consider concomitant pulmonary disease that may be associated with atrial tachycardias


  • Examine chest wall for the presence of an ICD or pacemaker that you can interrogate to reveal the atrial rhythm in difficult cases


  • Murmurs may point to cardiac disease in general, which is useful, but an S3 is suggestive of decompensated heart failure and can be the cause or result of an arrhythmia







FIGURE 6-1 Algorithm for initial approach to tachyarrhythmias. DDX, differential diagnosis; VT, ventricular tachycardia; SVT, supraventricular tachycardia; AVRT, atrioventricular reentrant tachycardia; ART, antidromic reciprocating tachycardia; ORT, orthodromic reciprocating tachycardia; AVNRT, A-V nodal reentrant tachycardia; AT, atrial tachycardia; JET, junctional ectopic tachycardia.


INITIAL MANAGEMENT



  • Always consider cardioversion for unstable arrhythmias. (See Figure 6-1.)


  • Obtain a baseline ECG for comparison whenever possible!


  • Attention to electrolyte abnormalities, especially ↓ K+ and Mg2+


  • If the patient has an ICD or pacemaker (particularly dual chamber), consider interrogation to help with workup of the arrhythmia


WIDE COMPLEX TACHYCARDIA (WCT)



  • Differential diagnosis includes VT versus SVT with aberrancy or pre-excited tachycardias. (See Table 6-1.)



    • Unselected population 80% of WCT = VT


    • Post-MI or structural heart disease 95% of WCT = VT5



    • Consider AF with antegrade conduction down an accessory pathway (pre-excited AF) if irregular with wide complex—avoid A-V nodal blockers can → VF


  • Misdiagnosis of a WCT as SVT when it is VT can have several consequences:



    • Acute progressive pump failure possible with incessant VT


    • Drugs: Verapamil, diltiazem, adenosine are potentially dangerous in VT


    • Failure to consider acute ischemia as an etiology of new onset VT








TABLE 6-1 Wide complex tachycardia: Differentiating VT from SVT















































Diagnostic Features


Ventricular Tachycardia


SVT with Aberrancy


Prior MI or structural heart disease


More likely


Less likely


WCT different in morphology from baseline QRS widening


More likely


Less likely


Right superior QRS axis


More likely


Less likely


A-V dissociation


Diagnostic



Fusion or capture beats


Diagnostic



Negative or positive concordance


>90% specific6



V1 positive WCT (RBBB pattern)7


V1: rsR’ (second R wave taller) >50:1 LR for VT V6: rS (small r, large S) >50:1 LR for VT



V1 negative WCT (LBBB pattern)7


V1: Broad initial R wave >40 ms favors VT


Absence of an R wave or <40 ms favors SVT



V1: Nadir of S wave >60 ms after initiation of QRS


Nadir of S wave <60 ms after initiation of QRS



V6: Q or QS favors VT LR >50:1


Absence of Q wave favors SVT

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 16, 2016 | Posted by in CARDIOLOGY | Comments Off on Wide and Narrow Complex Tachyarrhythmias

Full access? Get Clinical Tree

Get Clinical Tree app for offline access